243 related articles for article (PubMed ID: 22713481)
21. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
He S; Deng J; Li G; Wang B; Cao Y; Tu Y
Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
[TBL] [Abstract][Full Text] [Related]
22. Expression level of human miR-34a correlates with glioma grade and prognosis.
Gao H; Zhao H; Xiang W
J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas.
Zhang XK; Xi SY; Sai K; Chen HD; Zhong ZH; Wu QL; Zeng J
Int J Clin Exp Pathol; 2015; 8(5):5035-43. PubMed ID: 26191197
[TBL] [Abstract][Full Text] [Related]
24. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
[TBL] [Abstract][Full Text] [Related]
26. Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma.
Wang L; Yuan J; Tu Y; Mao X; He S; Fu G; Zong J; Zhang Y
Clin Transl Oncol; 2013 Feb; 15(2):139-45. PubMed ID: 22855183
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of N-methylpurine-DNA glycosylase influences patient survival in malignant gliomas.
Liu C; Tu Y; Yuan J; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
J Biomed Biotechnol; 2012; 2012():760679. PubMed ID: 22496614
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
Chen T; Wang XY; Li C; Xu SJ
Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of microRNA-17 predicts poor prognosis in human glioma.
Lu S; Wang S; Geng S; Ma S; Liang Z; Jiao B
J Biomed Biotechnol; 2012; 2012():970761. PubMed ID: 23226946
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma.
Wu Z; Wang L; Li G; Liu H; Fan F; Li Z; Li Y; Gao G
Mol Cell Biochem; 2013 Dec; 384(1-2):263-8. PubMed ID: 24122417
[TBL] [Abstract][Full Text] [Related]
31. Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Zhang Y; Gao G
J Exp Clin Cancer Res; 2012 May; 31(1):44. PubMed ID: 22578365
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
[TBL] [Abstract][Full Text] [Related]
34. CD24 expression as a marker for predicting clinical outcome in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
J Biomed Biotechnol; 2012; 2012():517172. PubMed ID: 22500096
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival.
Schittenhelm J; Trautmann K; Tabatabai G; Hermann C; Meyermann R; Beschorner R
Mod Pathol; 2009 Dec; 22(12):1600-11. PubMed ID: 19767728
[TBL] [Abstract][Full Text] [Related]
36. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
37. The Potential Prognostic Value of MicroRNA-429 for Human Gliomas.
Sun X; Li Z; Chen Y
Ann Clin Lab Sci; 2016; 46(1):44-8. PubMed ID: 26927341
[TBL] [Abstract][Full Text] [Related]
38. Increased argonaute 2 expression in gliomas and its association with tumor progression and poor prognosis.
Feng B; Hu P; Lu SJ; Chen JB; Ge RL
Asian Pac J Cancer Prev; 2014; 15(9):4079-83. PubMed ID: 24935600
[TBL] [Abstract][Full Text] [Related]
39. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
[TBL] [Abstract][Full Text] [Related]
40. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
